omniture

Cryoviva Bags Frost & Sullivan Thailand Stem Cell Company of the Year Award for Second Year in a Row

2016-03-31 12:00 3970

BANGKOK, March 31, 2016 /PRNewswire/ -- Cryoviva Thailand has been honored with the Frost & Sullivan Thailand Stem Cell Company of the Year award for the second consecutive years.

The award was presented to Cryoviva Thailand at the 2016 Frost & Sullivan Thailand Excellence Awards ceremony held at the Dusit Thani Bangkok on March 23.  

Mr. Chee Lip Lee, Research Analyst, Best Practices at Frost & Sullivan said that Cryoviva Thailand has provided valuable opportunities for its clients to have a credible and lifetime commitment with its excellent facilities and best practices.

He added that Cryoviva Thailand has given its clients assurance and total peace of mind through the credibility of the company, reputation of investors and rich experience in the industry. Based on the fundamentals of running cord blood banking operation, Cryoviva has had 0.001% client fall out.

"By continuously providing great value and world class standard of services to its clients in a variety of ways, the company has managed to maintain its leading position in Thailand's stem cell market," Mr. Lee added.

He also noted that Cryoviva is the first and only cord blood stem cell bank to be accredited by the American Association of Blood Banks (AABB) and IS9001 in Thailand. Mr. Lee added that Cryoviva's technology is licensed from Lifeforce Cryobanks USA, which is also accredited by AABB and FDA.

"We would like to thank Frost & Sullivan, a world leading consulting firm, for recognizing and awarding us the Thailand Stem Cell Company of the Year award for the second straight year," said Mrs. Chiranya Prachaseri, Chief Executive Officer at Cryoviva Thailand.

"The award is a validation of our excellent work in the stem cell industry in Thailand and the region. We remained committed to deliver excellence in the stem cell industry in Thailand and the region," she added.

The recipients of the 2016 Frost & Sullivan Thailand Excellence Awards were identified based on an in-depth research conducted by Frost & Sullivan's analysts. The short-listed companies were evaluated on a variety of actual market performance indicators which include revenue growth; market share and growth in market share; leadership in product innovation; marketing strategy and business development strategy.

About Cryoviva Thailand

Cryoviva (Thailand)Co., Ltd., is a private cord blood bank established in 2007 through the collaborative efforts of leading global organizations including Lifeforce Cryobanks USA, Cryobanks India, Indorama Ventures Thailand and RJ Corp., India.  The collaboration of these companies gives you access to stem cells -- the futuristic therapy with unlimited possibilities.  

At Cryoviva, we firmly believe that stem cells from umbilical cord blood and cord tissue are a true lifeline for a lifetime, a hope and promise for tomorrow's health and wellbeing. Cryoviva's mission is to be a lifetime partner for families and is committed to developing itself into a major player in biotechnology and healthcare, not only limited to stem cell, but also including stem cell therapy, and the storage and application of stem cells. While the global medical advancements today bring a new hope where stem cells from your baby's cord blood and cord tissue can be collected and stored for later use in the treatment of many life threatening diseases, Cryoviva believes that there will be a surge in interest amongst expecting couples as they become more aware of the developments, both in Thailand and globally.

Cryoviva's strategy is to continue to build branding, expand services options, and further access to high technologies whilst adhering to the highest quality standards and the best value price for our customers. Simultaneously, we aim to create new strategic partnerships that will allow us to boost awareness of the benefits of our services whilst also collaborating with those who with us and pushing for success in areas that are of mutual benefit as our strengths lie not only in stem cell banking but also in other areas of healthcare.

Cryoviva and all its group companies are accredited by the highest authorities in the field of business they engage in – this is a guarantee that we take our business seriously and assures our partners that we will maintain the highest standards of business in all our operations in the same way that our partners do by complying to standards such as JCI (Joint Commission International) for medical institutions.

In 2016, Cryoviva Thailand will place great focus on marketing activities to attract more customers and expand its database. Cryoviva intends to create a community for mothers for CRM purposes and will re-launch its brand to the market with a new perception. Cryoviva's CSR Project "Cryoviva for a New Life" will also be continued.

As Thailand's premium provider of stem cell banking services, we are fully committed to provide the best service delivery, quality and bringing state of the art technologies into our business for the maximum benefit of our customers.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. 

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?  

Contact Us:     Start the discussion

Media Contact

Alice Chia
Corporate Communications -- Asia Pacific
Frost & Sullivan
Email: alice.chia@frost.com

Source: Frost & Sullivan
collection